263 related articles for article (PubMed ID: 33495292)
21. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
22. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
23. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
Moy FM; Ray A; Buckley BS
Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
[TBL] [Abstract][Full Text] [Related]
24. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
25. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
[TBL] [Abstract][Full Text] [Related]
26. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
Polsky S; Garcetti R; Pyle L; Joshee P; Demmitt JK; Snell-Bergeon JK
PLoS One; 2020; 15(4):e0230476. PubMed ID: 32298269
[TBL] [Abstract][Full Text] [Related]
27. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
28. A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture.
Murphy HR
Diabetes Care; 2024 Mar; 47(3):324-330. PubMed ID: 38394634
[TBL] [Abstract][Full Text] [Related]
29. 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.
Nowak N; Skupien J; Cyganek K; Matejko B; Malecki MT
Diabetologia; 2013 Apr; 56(4):709-13. PubMed ID: 23377619
[TBL] [Abstract][Full Text] [Related]
30. The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial.
Ahmed RJ; Gafni A; Hutton EK; Hu ZJ; Sanchez JJ; Murphy HR; Feig DS;
CMAJ Open; 2021; 9(2):E627-E634. PubMed ID: 34088734
[TBL] [Abstract][Full Text] [Related]
31. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
[TBL] [Abstract][Full Text] [Related]
32. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.
O'Malley G; Ozaslan B; Levy CJ; Castorino K; Desjardins D; Levister C; McCrady-Spitzer S; Church MM; Kaur RJ; Reid C; Kremers WK; Doyle FJ; Trinidad MC; Rosenn B; Pinsker JE; Kudva YC; Dassau E
Diabetes Technol Ther; 2021 Dec; 23(12):807-817. PubMed ID: 34270347
[No Abstract] [Full Text] [Related]
34. Continuous glucose monitoring results in lower HbA
Paramasivam SS; Chinna K; Singh AKK; Ratnasingam J; Ibrahim L; Lim LL; Tan ATB; Chan SP; Tan PC; Omar SZ; Bilous RW; Vethakkan SR
Diabet Med; 2018 Aug; 35(8):1118-1129. PubMed ID: 29663517
[TBL] [Abstract][Full Text] [Related]
35. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
[TBL] [Abstract][Full Text] [Related]
36. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
[TBL] [Abstract][Full Text] [Related]
38. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
[No Abstract] [Full Text] [Related]
39. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
40. Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy.
Scott EM; Murphy HR; Kristensen KH; Feig DS; Kjölhede K; Englund-Ögge L; Berntorp KE; Law GR
Diabetes Care; 2022 Aug; 45(8):1724-1734. PubMed ID: 35696191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
